Time to Surgery Does Not Affect Overall or Disease-Free Survival of Patients with Primary Resectable PDAC

(1) Background: Delay in therapy for pancreatic ductal adenocarcinoma (PDAC) may contribute to a worse outcome. The aim of this study was to investigate the prognostic value of time from diagnosis to surgery in patients undergoing upfront surgery for primarily resectable pancreatic carcinoma. (2) Methods: This retrospective single-center study included 214 patients who underwent primary resection of PDAC from January 2000 to December 2018 at University Hospital Erlangen. Using a minimum p-value approach, patients were stratified according to time to surgery (TtS) into two groups: TtS ≤ 23 days and TtS > 23 days. Postoperative outcome and long-term survival were compared. (3) Results: Median TtS was 25 days. The best cut-off for TtS was determined as 23 days. There were no differences regarding postoperative outcome or overall survival (OS) and disease-free survival (DFS) (OS: 23.8 vs. 20.4 months, p = 0.210, respectively, and DFS: 15.8 vs. 13.6 months, p = 0.187). Multivariate analysis revealed age, lymph node metastasis, tumor differentiation and resection status as significant independent prognostic predictors for OS and DFS. (4) Conclusions: A delay of surgery > 23 days after first diagnosis does not affect overall or disease-free survival of patients with primary resectable PDAC. However, the psychological impact of a delay to patients waiting for surgery should not be underestimated.

[1]  A. Zwinderman,et al.  Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[3]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[4]  N. Demartines,et al.  Prognostic Impact of Time to Surgery in Patients With Resectable Pancreatic Ductal Adenocarcinoma , 2021, Pancreas.

[5]  I. de Hingh,et al.  Impact of time interval between multidisciplinary team meeting and intended pancreatoduodenectomy on oncological outcomes , 2020, BJS open.

[6]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[7]  Katelin A Mirkin,et al.  Time to Surgery: a Misguided Quality Metric in Early Stage Pancreatic Cancer , 2018, Journal of Gastrointestinal Surgery.

[8]  C. Bassi,et al.  Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[9]  S. Pal,et al.  The International Study Group of Pancreatic Surgery definition of delayed gastric emptying and the effects of various surgical modifications on the occurrence of delayed gastric emptying after pancreatoduodenectomy. , 2017, Hepatobiliary & pancreatic diseases international : HBPD INT.

[10]  D. Mirza,et al.  A reduced time to surgery within a 'fast track' pathway for periampullary malignancy is associated with an increased rate of pancreatoduodenectomy. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[11]  V. Bouvier,et al.  Pancreatic cancer: Wait times from presentation to treatment and survival in a population‐based study , 2016, International journal of cancer.

[12]  A. Andrén-sandberg,et al.  Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer , 2016, The British journal of surgery.

[13]  Michael Goggins,et al.  Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages , 2015, Gut.

[14]  K. Gurusamy,et al.  Meta‐analysis of randomized clinical trials on safety and efficacy of biliary drainage before surgery for obstructive jaundice , 2013, The British journal of surgery.

[15]  O. Bathe,et al.  The Effect of Wait Times on Oncological Outcomes From Periampullary Adenocarcinomas , 2013, Journal of surgical oncology.

[16]  K. Lassen,et al.  Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. , 2012, Clinical nutrition.

[17]  Joshua A. Waters,et al.  Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma? , 2011, Surgery.

[18]  D. Gouma,et al.  Therapeutic Delay and Survival After Surgery for Cancer of the Pancreatic Head With or Without Preoperative Biliary Drainage , 2010, Annals of surgery.

[19]  D. Raptis,et al.  Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. , 2010, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[20]  D. Gouma,et al.  Preoperative biliary drainage for cancer of the head of the pancreas. , 2010, The New England journal of medicine.

[21]  Abe Fingerhut,et al.  Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. , 2007, Surgery.

[22]  D. Gouma,et al.  Quality of life in newly diagnosed cancer patients waiting for surgery is seriously impaired , 2006, Journal of surgical oncology.

[23]  J. Neoptolemos,et al.  Postoperative pancreatic fistula: an international study group (ISGPF) definition. , 2005, Surgery.

[24]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[25]  E. Diamandis,et al.  Pancreatic cancer. , 2013, Clinical chemistry.

[26]  K. Lassen,et al.  Guidelines for Perioperative Care for Pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations , 2012, World Journal of Surgery.